Literature DB >> 3031646

Human salivary gustin is a potent activator of calmodulin-dependent brain phosphodiesterase.

J S Law, N Nelson, K Watanabe, R I Henkin.   

Abstract

Human salivary gustin stimulated activity of brain calmodulin-dependent cyclic nucleotide phosphodiesterase (cAMP PDEase; 3',5'-cyclic-nucleotide phosphodiesterase, EC 3.1.4.17) in a dose-dependent manner in the absence of calmodulin. At physiological levels found in human saliva, gustin activated cAMP PDEase 5- to 6-fold. Activation of PDEase occurred with as little as 500 ng of gustin. Comparative sensitivity of activation of PDEase by gustin was intermediate between calmodulin and lysophosphatidylcholine with maximal activation and half-maximal activation (indicated in parentheses) at 3 X 10(-8) M (4.3 X 10(-9) M), 3.4 X 10(-6) M (3.4 X 10(-7) M), and 2.5 X 10(-3) M (4.0 X 10(-5) M) for calmodulin, gustin, and lysophosphatidylcholine, respectively. No other major salivary protein activated PDEase. Anticalmodulin antibody completely inhibited calmodulin-activated cAMP PDEase activity, but the antibody had no effect on gustin-activated cAMP PDEase activity. A sensitive calmodulin RIA indicated that no calmodulin was detected in any gustin preparation that activated cAMP PDEase. Both gustin and calmodulin rendered cAMP PDEase thermally labile to a similar extent and increased Vmax without affecting the apparent Km for the substrate cAMP. Activation by gustin and calmodulin was unaffected by lubrol-PX, trypsin inhibitor, pepstatin A, or leupeptin. In the presence of 1 mM EGTA, gustin activated cAMP PDE 5- to 6-fold, but the activating ability was completely lost after gustin was heated at 100 degrees C for 5 min. In contrast, calmodulin lost all activating ability in the presence of 1 mM EGTA, whereas heating calmodulin at 100 degrees C for 5 min did not affect its activation of cAMP PDEase. Lysophosphatidylcholine-activation of cAMP PDEase, like gustin activation, was unaffected by EGTA, but lysophosphatidylcholine-activation of cAMP PDEase, like calmodulin activation, was unaffected by heating at 100 degrees C for 5 min.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031646      PMCID: PMC304499          DOI: 10.1073/pnas.84.6.1674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Defects of taste and smell in patients with hypothyroidism.

Authors:  R J McConnell; C E Menendez; F R Smith; R I Henkin; R S Rivlin
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  A zinc protein isolated from human parotid saliva.

Authors:  R I Henkin; R E Lippoldt; J Bilstad; H Edelhoch
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

3.  A modified assay of 3':5'-cyclic-AMP phosphodiesterase.

Authors:  R J Boudreau; G I Drummond
Journal:  Anal Biochem       Date:  1975-02       Impact factor: 3.365

4.  Calcium-dependent cyclic nucleotide phosphodiesterase from brain identification of phospholipids as calcium-independent activators.

Authors:  D J Wolff; C O Brostrom
Journal:  Arch Biochem Biophys       Date:  1976-04       Impact factor: 4.013

5.  Cyclic 3',5'-nucleotide phosphodiesterase: pronounced stimulation by snake venom.

Authors:  W Y Cheung
Journal:  Biochem Biophys Res Commun       Date:  1967-11-30       Impact factor: 3.575

6.  Cyclic 3':5'-nucleotide phosphodiesterase. Purification, characterization, and active form of the protein activator from bovine brain.

Authors:  Y M Lin; Y P Liu; W Y Cheung
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

7.  Inhibition of cyclic 3',5'-nucleotide phosphodiesterase in bovine taste papillae by bitter taste stimuli.

Authors:  K Kurihara
Journal:  FEBS Lett       Date:  1972-11-01       Impact factor: 4.124

8.  Phosphodiesterase in tongue epithelium: activation by bitter taste stimuli.

Authors:  S Price
Journal:  Nature       Date:  1973-01-05       Impact factor: 49.962

9.  Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator.

Authors:  W Y Cheung
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

10.  Estimation of zinc concentration of parotid saliva by flameless atomic absorption spectrophotometry in normal subjects and in patients with idiopathic hypogeusia.

Authors:  R I Henkin; C W Mueller; R O Wolf
Journal:  J Lab Clin Med       Date:  1975-07
View more
  3 in total

Review 1.  Zinc status in athletes: relation to diet and exercise.

Authors:  A Micheletti; R Rossi; S Rufini
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk.

Authors:  P Karhumaa; J Leinonen; S Parkkila; K Kaunisto; J Tapanainen; H Rajaniemi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 3.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.